Understanding the opportunity to sell directly to patients via a cash model
Are Direct-to-Patient Access Models the Future of Pharma?
read more
BLOG
How To Maximize Biotech Vendor Marketing
Biotech marketing requires a unique blend of scientific expertise, strategic planning, and creative execution.
Hub Implementation: The Key to Product Launches
Hub Implementation: The Key to Product Launches
Revving Up for 2024: Market Access Kick-Start Resources
Revving Up for 2024: Market Access Kick-Start Resources
Key Market Access Trends to Watch in 2024
Key Market Access Trends to Watch in 2024
The Key to Pharmaceutical Commercial Success
The Key to Pharmaceutical Commercial Success
Outlook on Oncology: Key Takeaways from the AVBCC 2023 Educational Summit
Outlook on Oncology: Key Takeaways from the AVBCC 2023 Educational Summit
Prior Authorization Should be a Top Concern for Pharma — Here’s Why
Prior Authorization Should be a Top Concern for Pharma — Here’s Why
Webinar Archive: Pharmaceutical HUBs are Underutilized; Yours Doesn’t Have to Be
HUBs are Underutilized; Yours Doesn’t Have to Be
Key Takeaways from the Health Systems & Pharma Partnering Summit 2023
Key Takeaways from the Health Systems & Pharma Partnering Summit 2023
Risk vs. Reward: A Must-Have Contracting Guide for Specialty Pharmacy Services
Risk vs. Reward: A Must-Have Contracting Guide for Specialty Pharmacy Services
Five Takeaways from Medicare’s 10 Drugs Up for Price Negotiation
Five Takeaways from Medicare’s 10 Drugs Up for Price Negotiation
Pharma Has a Pull-Through Problem; The Answer is Data
Pharma Has a Pull-Through Problem; The Answer is Data
Are Alternative Distribution Models a Viable Option for Pharma?
As seen in Pharmaceutical Commerce: Key considerations for drug manufacturers pursuing an effective alternative distribution model
Using Targeted Market Research to Improve Future Adoption of Cell and Gene Therapies
Using Targeted Market Research to Improve Future Adoption of Cell and Gene Therapies
How Pharma Can Turn Data into Insights: Effectively Leveraging Pharma and Market Access Data
How Pharma Can Turn Data into Insights: Effectively Leveraging Pharma and Market Access Data
Take the Pain out of Conversations About Coverage
Take the Pain out of Conversations About Coverage
Market Access POV: ICER and Specialty Drug Coverage
Market Access POV: ICER and Specialty Drug Coverage
Key Takeaways from the 2023 Asembia Specialty Pharmacy Summit
Key Takeaways from the 2023 Asembia Specialty Pharmacy Summit
Specialty Pharmacy Services Fair Market Value Benchmark Report
Specialty Pharmacy Services Fair Market Value Benchmark Report
3PL Health Checks Generate Savings for Manufacturers: Here’s How to Begin
3PL Health Checks Generate Savings for Manufacturers: Here’s How to Begin
3 Market Access Takeaways from SXSW 2023
What market access teams should be thinking about after 2023’s SXSW Conference
How to Prepare for DSCSA D-Day
For manufacturers who haven’t started preparing for DSCSA D-Day, the “OH NO!” moment is here, but this article can help.
Effective and Practical Ways to Impact Health Inequity Now
Practical lists of questions spanning distribution, access, and affordability that market access teams can use to impact health equity today